Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October’s correction, which whittled more than 10% off the Nasdaq. Alexion Pharmaceuticals (ALXN), which develops drugs that treat blood disorders, is extended from a 179.69 buy point from a cup-with-handle base that began in February.